お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、吸入セボフルラン麻酔薬の世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に吸入セボフルラン麻酔薬市場を分類しています。
本レポートでは世界の吸入セボフルラン麻酔薬市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Hengrui、Baxter、Maruishi、AbbVie、Piramal、Viatris、PT Novell Pharmaceutical、Lunan Pharma

レポートは吸入セボフルラン麻酔薬の主要生産者を調査し、主要地域や国の消費状況も提供します。吸入セボフルラン麻酔薬の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    250ml/Bottle
    120ml/Bottle
    Other

用途別の市場セグメント：
    Hospital
    Clinics
    Other

本レポートの詳細内容
本レポートは、世界の吸入セボフルラン麻酔薬市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて吸入セボフルラン麻酔薬市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別（地域レベル、国レベル）の吸入セボフルラン麻酔薬生産量、成長率、市場シェアを調査している。

二. 消費面では、吸入セボフルラン麻酔薬の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。

三.主要メーカーの吸入セボフルラン麻酔薬売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界の吸入セボフルラン麻酔薬市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本吸入セボフルラン麻酔薬のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：吸入セボフルラン麻酔薬のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2020～2031）
第2章： 吸入セボフルラン麻酔薬の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2020～2031）
第3章：世界、地域、国レベルにおける吸入セボフルラン麻酔薬の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2020～2031）
第4章吸入セボフルラン麻酔薬メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2020～2025）
第5章：吸入セボフルラン麻酔薬の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2020～2031）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2020～2031）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2020～2031）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第12章：吸入セボフルラン麻酔薬の主要メーカーの概要を提供し、製品の説明と仕様、吸入セボフルラン麻酔薬の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2020～2025）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：吸入セボフルラン麻酔薬の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
The global Inhalation Sevoflurane Anaesthetic Agent market is projected to grow from US$ 1195 million in 2024 to US$ 1479 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.6% during the forecast period.
The key driver for the Sevoflurane market is the increasing number of surgeries worldwide, driven by the aging population and the rising prevalence of chronic conditions requiring surgical intervention. Sevoflurane is highly preferred due to its rapid onset and recovery, making it ideal for both pediatric and adult patients, particularly in outpatient surgeries. Technological advancements in anesthesia delivery systems and the growing demand for minimally invasive procedures have also contributed to the rising adoption of Sevoflurane in clinical settings. Furthermore, the safety and effectiveness of Sevoflurane in maintaining stable cardiovascular function during anesthesia have enhanced its demand.
One of the main challenges in the Sevoflurane market is its high cost compared to other anesthetic agents, which can limit its accessibility in low- and middle-income regions. Additionally, environmental concerns regarding the use of volatile anesthetics like Sevoflurane, which contribute to greenhouse gas emissions, have led to increased scrutiny and calls for more sustainable alternatives. Regulatory restrictions and the availability of generic alternatives may further impact the market growth, as healthcare providers seek more cost-effective or environmentally friendly options.
Report Includes
This report presents an overview of global market for Inhalation Sevoflurane Anaesthetic Agent, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Inhalation Sevoflurane Anaesthetic Agent, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Inhalation Sevoflurane Anaesthetic Agent, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Inhalation Sevoflurane Anaesthetic Agent sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Inhalation Sevoflurane Anaesthetic Agent market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Inhalation Sevoflurane Anaesthetic Agent sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Hengrui, Baxter, Maruishi, AbbVie, Piramal, Viatris, PT Novell Pharmaceutical, Lunan Pharma, etc.

Market Segmentation
By Company
    Hengrui
    Baxter
    Maruishi
    AbbVie
    Piramal
    Viatris
    PT Novell Pharmaceutical
    Lunan Pharma

Segment by Type
    250ml/Bottle
    120ml/Bottle
    Other

Segment by Application
    Hospital
    Clinics
    Other

Segment by region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia

Middle East, Africa, Latin America
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Inhalation Sevoflurane Anaesthetic Agent in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Inhalation Sevoflurane Anaesthetic Agent manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Inhalation Sevoflurane Anaesthetic Agent sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
 Table 1. Global Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Table 2. Major Manufacturers of 250ml/Bottle
 Table 3. Major Manufacturers of 120ml/Bottle
 Table 4. Major Manufacturers of Other
 Table 5. Global Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Table 6. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 7. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2019-2024) & (US$ Million)
 Table 8. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2025-2030) & (US$ Million)
 Table 9. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2019-2024)
 Table 10. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2025-2030)
 Table 11. Global Inhalation Sevoflurane Anaesthetic Agent Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
 Table 12. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2019-2024) & (K Units)
 Table 13. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2025-2030) & (K Units)
 Table 14. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2019-2024)
 Table 15. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2025-2030)
 Table 16. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Manufacturers (2019-2024) & (K Units)
 Table 17. Global Inhalation Sevoflurane Anaesthetic Agent Sales Share by Manufacturers (2019-2024)
 Table 18. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Manufacturers (2019-2024) & (US$ Million)
 Table 19. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Manufacturers (2019-2024)
 Table 20. Global Key Players of Inhalation Sevoflurane Anaesthetic Agent, Industry Ranking, 2021 VS 2022 VS 2023
 Table 21. Inhalation Sevoflurane Anaesthetic Agent Price by Manufacturers (2019-2024) & (US$/Unit)
 Table 22. Global Inhalation Sevoflurane Anaesthetic Agent Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 23. Global Inhalation Sevoflurane Anaesthetic Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalation Sevoflurane Anaesthetic Agent as of 2023)
 Table 24. Global Key Manufacturers of Inhalation Sevoflurane Anaesthetic Agent, Manufacturing Base Distribution and Headquarters
 Table 25. Global Key Manufacturers of Inhalation Sevoflurane Anaesthetic Agent, Product Offered and Application
 Table 26. Global Key Manufacturers of Inhalation Sevoflurane Anaesthetic Agent, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2019-2024) & (K Units)
 Table 29. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2025-2030) & (K Units)
 Table 30. Global Inhalation Sevoflurane Anaesthetic Agent Sales Share by Type (2019-2024)
 Table 31. Global Inhalation Sevoflurane Anaesthetic Agent Sales Share by Type (2025-2030)
 Table 32. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2019-2024) & (US$ Million)
 Table 33. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2025-2030) & (US$ Million)
 Table 34. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Type (2019-2024)
 Table 35. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Type (2025-2030)
 Table 36. Inhalation Sevoflurane Anaesthetic Agent Price by Type (2019-2024) & (US$/Unit)
 Table 37. Global Inhalation Sevoflurane Anaesthetic Agent Price Forecast by Type (2025-2030) & (US$/Unit)
 Table 38. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2019-2024) & (K Units)
 Table 39. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2025-2030) & (K Units)
 Table 40. Global Inhalation Sevoflurane Anaesthetic Agent Sales Share by Application (2019-2024)
 Table 41. Global Inhalation Sevoflurane Anaesthetic Agent Sales Share by Application (2025-2030)
 Table 42. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2019-2024) & (US$ Million)
 Table 43. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2025-2030) & (US$ Million)
 Table 44. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Application (2019-2024)
 Table 45. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Application (2025-2030)
 Table 46. Inhalation Sevoflurane Anaesthetic Agent Price by Application (2019-2024) & (US$/Unit)
 Table 47. Global Inhalation Sevoflurane Anaesthetic Agent Price Forecast by Application (2025-2030) & (US$/Unit)
 Table 48. US & Canada Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2019-2024) & (K Units)
 Table 49. US & Canada Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2025-2030) & (K Units)
 Table 50. US & Canada Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2019-2024) & (US$ Million)
 Table 51. US & Canada Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2025-2030) & (US$ Million)
 Table 52. US & Canada Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2019-2024) & (K Units)
 Table 53. US & Canada Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2025-2030) & (K Units)
 Table 54. US & Canada Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2019-2024) & (US$ Million)
 Table 55. US & Canada Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2025-2030) & (US$ Million)
 Table 56. US & Canada Inhalation Sevoflurane Anaesthetic Agent Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 57. US & Canada Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2019-2024) & (US$ Million)
 Table 58. US & Canada Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2025-2030) & (US$ Million)
 Table 59. US & Canada Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2019-2024) & (K Units)
 Table 60. US & Canada Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2025-2030) & (K Units)
 Table 61. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2019-2024) & (K Units)
 Table 62. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2025-2030) & (K Units)
 Table 63. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2019-2024) & (US$ Million)
 Table 64. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2025-2030) & (US$ Million)
 Table 65. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2019-2024) & (K Units)
 Table 66. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2025-2030) & (K Units)
 Table 67. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2019-2024) & (US$ Million)
 Table 68. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2025-2030) & (US$ Million)
 Table 69. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 70. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2019-2024) & (US$ Million)
 Table 71. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2025-2030) & (US$ Million)
 Table 72. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2019-2024) & (K Units)
 Table 73. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2025-2030) & (K Units)
 Table 74. China Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2019-2024) & (K Units)
 Table 75. China Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2025-2030) & (K Units)
 Table 76. China Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2019-2024) & (US$ Million)
 Table 77. China Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2025-2030) & (US$ Million)
 Table 78. China Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2019-2024) & (K Units)
 Table 79. China Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2025-2030) & (K Units)
 Table 80. China Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2019-2024) & (US$ Million)
 Table 81. China Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2025-2030) & (US$ Million)
 Table 82. Asia Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2019-2024) & (K Units)
 Table 83. Asia Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2025-2030) & (K Units)
 Table 84. Asia Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2019-2024) & (US$ Million)
 Table 85. Asia Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2025-2030) & (US$ Million)
 Table 86. Asia Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2019-2024) & (K Units)
 Table 87. Asia Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2025-2030) & (K Units)
 Table 88. Asia Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2019-2024) & (US$ Million)
 Table 89. Asia Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2025-2030) & (US$ Million)
 Table 90. Asia Inhalation Sevoflurane Anaesthetic Agent Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 91. Asia Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2019-2024) & (US$ Million)
 Table 92. Asia Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2025-2030) & (US$ Million)
 Table 93. Asia Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2019-2024) & (K Units)
 Table 94. Asia Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2025-2030) & (K Units)
 Table 95. Middle East, Africa and Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2019-2024) & (K Units)
 Table 96. Middle East, Africa and Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2025-2030) & (K Units)
 Table 97. Middle East, Africa and Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2019-2024) & (US$ Million)
 Table 98. Middle East, Africa and Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2025-2030) & (US$ Million)
 Table 99. Middle East, Africa and Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2019-2024) & (K Units)
 Table 100. Middle East, Africa and Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2025-2030) & (K Units)
 Table 101. Middle East, Africa and Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2019-2024) & (US$ Million)
 Table 102. Middle East, Africa and Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2025-2030) & (US$ Million)
 Table 103. Middle East, Africa and Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 104. Middle East, Africa and Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2019-2024) & (US$ Million)
 Table 105. Middle East, Africa and Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2025-2030) & (US$ Million)
 Table 106. Middle East, Africa and Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2019-2024) & (K Units)
 Table 107. Middle East, Africa and Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2025-2030) & (K Units)
 Table 108. Hengrui Company Information
 Table 109. Hengrui Description and Major Businesses
 Table 110. Hengrui Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 111. Hengrui Inhalation Sevoflurane Anaesthetic Agent Product Model Numbers, Pictures, Descriptions and Specifications
 Table 112. Hengrui Recent Developments
 Table 113. Baxter Company Information
 Table 114. Baxter Description and Major Businesses
 Table 115. Baxter Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 116. Baxter Inhalation Sevoflurane Anaesthetic Agent Product Model Numbers, Pictures, Descriptions and Specifications
 Table 117. Baxter Recent Developments
 Table 118. Maruishi Company Information
 Table 119. Maruishi Description and Major Businesses
 Table 120. Maruishi Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 121. Maruishi Inhalation Sevoflurane Anaesthetic Agent Product Model Numbers, Pictures, Descriptions and Specifications
 Table 122. Maruishi Recent Developments
 Table 123. AbbVie Company Information
 Table 124. AbbVie Description and Major Businesses
 Table 125. AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 126. AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Model Numbers, Pictures, Descriptions and Specifications
 Table 127. AbbVie Recent Developments
 Table 128. Piramal Company Information
 Table 129. Piramal Description and Major Businesses
 Table 130. Piramal Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 131. Piramal Inhalation Sevoflurane Anaesthetic Agent Product Model Numbers, Pictures, Descriptions and Specifications
 Table 132. Piramal Recent Developments
 Table 133. Viatris Company Information
 Table 134. Viatris Description and Major Businesses
 Table 135. Viatris Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 136. Viatris Inhalation Sevoflurane Anaesthetic Agent Product Model Numbers, Pictures, Descriptions and Specifications
 Table 137. Viatris Recent Developments
 Table 138. PT Novell Pharmaceutical Company Information
 Table 139. PT Novell Pharmaceutical Description and Major Businesses
 Table 140. PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 141. PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Model Numbers, Pictures, Descriptions and Specifications
 Table 142. PT Novell Pharmaceutical Recent Developments
 Table 143. Lunan Pharma Company Information
 Table 144. Lunan Pharma Description and Major Businesses
 Table 145. Lunan Pharma Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 146. Lunan Pharma Inhalation Sevoflurane Anaesthetic Agent Product Model Numbers, Pictures, Descriptions and Specifications
 Table 147. Lunan Pharma Recent Developments
 Table 148. Key Raw Materials Lists
 Table 149. Raw Materials Key Suppliers Lists
 Table 150. Inhalation Sevoflurane Anaesthetic Agent Distributors List
 Table 151. Inhalation Sevoflurane Anaesthetic Agent Customers List
 Table 152. Inhalation Sevoflurane Anaesthetic Agent Market Trends
 Table 153. Inhalation Sevoflurane Anaesthetic Agent Market Drivers
 Table 154. Inhalation Sevoflurane Anaesthetic Agent Market Challenges
 Table 155. Inhalation Sevoflurane Anaesthetic Agent Market Restraints
 Table 156. Research Programs/Design for This Report
 Table 157. Key Data Information from Secondary Sources
 Table 158. Key Data Information from Primary Sources


List of Figures
 Figure 1. Inhalation Sevoflurane Anaesthetic Agent Product Picture
 Figure 2. Global Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 3. Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Type: 2023 & 2030
 Figure 4. 250ml/Bottle Product Picture
 Figure 5. 120ml/Bottle Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 8. Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Application: 2023 & 2030
 Figure 9. Hospital
 Figure 10. Clinics
 Figure 11. Other
 Figure 12. Inhalation Sevoflurane Anaesthetic Agent Report Years Considered
 Figure 13. Global Inhalation Sevoflurane Anaesthetic Agent Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global Inhalation Sevoflurane Anaesthetic Agent Revenue (2019-2030) & (US$ Million)
 Figure 15. Global Inhalation Sevoflurane Anaesthetic Agent Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Figure 16. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region in Percentage: 2023 Versus 2030
 Figure 17. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2019-2030)
 Figure 18. Global Inhalation Sevoflurane Anaesthetic Agent Sales (2019-2030) & (K Units)
 Figure 19. Global Inhalation Sevoflurane Anaesthetic Agent Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
 Figure 20. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2019-2030)
 Figure 21. US & Canada Inhalation Sevoflurane Anaesthetic Agent Sales YoY (2019-2030) & (K Units)
 Figure 22. US & Canada Inhalation Sevoflurane Anaesthetic Agent Revenue YoY (2019-2030) & (US$ Million)
 Figure 23. Europe Inhalation Sevoflurane Anaesthetic Agent Sales YoY (2019-2030) & (K Units)
 Figure 24. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue YoY (2019-2030) & (US$ Million)
 Figure 25. China Inhalation Sevoflurane Anaesthetic Agent Sales YoY (2019-2030) & (K Units)
 Figure 26. China Inhalation Sevoflurane Anaesthetic Agent Revenue YoY (2019-2030) & (US$ Million)
 Figure 27. Asia (excluding China) Inhalation Sevoflurane Anaesthetic Agent Sales YoY (2019-2030) & (K Units)
 Figure 28. Asia (excluding China) Inhalation Sevoflurane Anaesthetic Agent Revenue YoY (2019-2030) & (US$ Million)
 Figure 29. Middle East, Africa and Latin America Inhalation Sevoflurane Anaesthetic Agent Sales YoY (2019-2030) & (K Units)
 Figure 30. Middle East, Africa and Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue YoY (2019-2030) & (US$ Million)
 Figure 31. Global Inhalation Sevoflurane Anaesthetic Agent Sales Share by Manufacturers (2023)
 Figure 32. The Inhalation Sevoflurane Anaesthetic Agent Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
 Figure 33. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Manufacturers (2023)
 Figure 34. The Top 5 and 10 Largest Manufacturers of Inhalation Sevoflurane Anaesthetic Agent in the World: Market Share by Inhalation Sevoflurane Anaesthetic Agent Revenue in 2023
 Figure 35. Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 36. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2019-2030)
 Figure 37. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2019-2030)
 Figure 38. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2019-2030)
 Figure 39. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2019-2030)
 Figure 40. US & Canada Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2019-2030)
 Figure 41. US & Canada Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2019-2030)
 Figure 42. US & Canada Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2019-2030)
 Figure 43. US & Canada Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2019-2030)
 Figure 44. US & Canada Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Country (2019-2030)
 Figure 45. US & Canada Inhalation Sevoflurane Anaesthetic Agent Sales Share by Country (2019-2030)
 Figure 46. US Inhalation Sevoflurane Anaesthetic Agent Revenue (2019-2030) & (US$ Million)
 Figure 47. Canada Inhalation Sevoflurane Anaesthetic Agent Revenue (2019-2030) & (US$ Million)
 Figure 48. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2019-2030)
 Figure 49. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2019-2030)
 Figure 50. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2019-2030)
 Figure 51. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2019-2030)
 Figure 52. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Country (2019-2030)
 Figure 53. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Share by Country (2019-2030)
 Figure 54. Germany Inhalation Sevoflurane Anaesthetic Agent Revenue (2019-2030) & (US$ Million)
 Figure 55. France Inhalation Sevoflurane Anaesthetic Agent Revenue (2019-2030) & (US$ Million)
 Figure 56. U.K. Inhalation Sevoflurane Anaesthetic Agent Revenue (2019-2030) & (US$ Million)
 Figure 57. Italy Inhalation Sevoflurane Anaesthetic Agent Revenue (2019-2030) & (US$ Million)
 Figure 58. Russia Inhalation Sevoflurane Anaesthetic Agent Revenue (2019-2030) & (US$ Million)
 Figure 59. China Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2019-2030)
 Figure 60. China Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2019-2030)
 Figure 61. China Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2019-2030)
 Figure 62. China Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2019-2030)
 Figure 63. Asia Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2019-2030)
 Figure 64. Asia Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2019-2030)
 Figure 65. Asia Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2019-2030)
 Figure 66. Asia Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2019-2030)
 Figure 67. Asia Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Region (2019-2030)
 Figure 68. Asia Inhalation Sevoflurane Anaesthetic Agent Sales Share by Region (2019-2030)
 Figure 69. Japan Inhalation Sevoflurane Anaesthetic Agent Revenue (2019-2030) & (US$ Million)
 Figure 70. South Korea Inhalation Sevoflurane Anaesthetic Agent Revenue (2019-2030) & (US$ Million)
 Figure 71. China Taiwan Inhalation Sevoflurane Anaesthetic Agent Revenue (2019-2030) & (US$ Million)
 Figure 72. Southeast Asia Inhalation Sevoflurane Anaesthetic Agent Revenue (2019-2030) & (US$ Million)
 Figure 73. India Inhalation Sevoflurane Anaesthetic Agent Revenue (2019-2030) & (US$ Million)
 Figure 74. Australia Inhalation Sevoflurane Anaesthetic Agent Revenue (2019-2030) & (US$ Million)
 Figure 75. Middle East, Africa and Latin America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2019-2030)
 Figure 76. Middle East, Africa and Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2019-2030)
 Figure 77. Middle East, Africa and Latin America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2019-2030)
 Figure 78. Middle East, Africa and Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2019-2030)
 Figure 79. Middle East, Africa and Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Country (2019-2030)
 Figure 80. Middle East, Africa and Latin America Inhalation Sevoflurane Anaesthetic Agent Sales Share by Country (2019-2030)
 Figure 81. Brazil Inhalation Sevoflurane Anaesthetic Agent Revenue (2019-2030) & (US$ Million)
 Figure 82. Mexico Inhalation Sevoflurane Anaesthetic Agent Revenue (2019-2030) & (US$ Million)
 Figure 83. Turkey Inhalation Sevoflurane Anaesthetic Agent Revenue (2019-2030) & (US$ Million)
 Figure 84. Israel Inhalation Sevoflurane Anaesthetic Agent Revenue (2019-2030) & (US$ Million)
 Figure 85. GCC Countries Inhalation Sevoflurane Anaesthetic Agent Revenue (2019-2030) & (US$ Million)
 Figure 86. Inhalation Sevoflurane Anaesthetic Agent Value Chain
 Figure 87. Inhalation Sevoflurane Anaesthetic Agent Production Process
 Figure 88. Channels of Distribution (Direct Vs Distribution)
 Figure 89. Bottom-up and Top-down Approaches for This Report
 Figure 90. Data Triangulation
 Figure 91. Key Executives Interviewed